Search Results - "CHIEFFO, Nicole"

Abiraterone and Increased Survival in Metastatic Prostate Cancer by de Bono, Johann S, Logothetis, Christopher J, Molina, Arturo, Fizazi, Karim, North, Scott, Chu, Luis, Chi, Kim N, Jones, Robert J, Goodman, Oscar B, Saad, Fred, Staffurth, John N, Mainwaring, Paul, Harland, Stephen, Flaig, Thomas W, Hutson, Thomas E, Cheng, Tina, Patterson, Helen, Hainsworth, John D, Ryan, Charles J, Sternberg, Cora N, Ellard, Susan L, Fléchon, Aude, Saleh, Mansoor, Scholz, Mark, Efstathiou, Eleni, Zivi, Andrea, Bianchini, Diletta, Loriot, Yohann, Chieffo, Nicole, Kheoh, Thian, Haqq, Christopher M, Scher, Howard I

“…In this study, abiraterone acetate inhibited androgen synthesis and prolonged survival by 4 months among men with castration-resistant prostate cancer that had…”
Get full text

Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone by EFSTATHIOU, Eleni, TITUS, Mark, TRONCOSO, Patricia, LOGOTHETIS, Christopher T, TSAVACHIDOU, Dimitra, TZELEPI, Vassiliki, SIJIN WEN, HOANG, Anh, MOLINA, Arturo, CHIEFFO, Nicole, SMITH, Lisa A, KARLOU, Maria

“…Persistent androgen signaling is implicated in castrate-resistant prostate cancer (CRPC) progression. This study aimed to evaluate androgen signaling in bone…”
Get full text

Abstract LB-421: Characterization of castrate resistant prostate cancer treated with abiraterone acetate and prednisone by Efstathiou, Eleni, Titus, Mark, Tsavachidou, Dimitra, Tzelepi, Vassiliki, Wen, Sijin, Hoang, Anh, Molina, Arturo, Chieffo, Nicole, Smith, Lisa A., Smith, BS RN, Karlou, Maria Karlou, Troncoso, Patricia, Logothetis, Christopher J.

“…Abstract Background: Recent observations implicate persistent androgen signaling in metastatic castrate-resistant prostate cancer (mCRPC) progression…”
Get full text

Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis by Gottlieb, Alice B, Kang, Sewon, Linden, Kenneth G, Lebwohl, Mark, Menter, Alan, Abdulghani, Ahsan A, Goldfarb, Michael, Chieffo, Nicole, Totoritis, Mark C

“…Background: Reduction in lesional, activated T cells induces improvement in psoriatic plaques. Galiximab (IDEC-114), an IgG 1 anti-CD80 antibody, binds to…”
Get full text